AroCell Investor Relations Material

AroCell AB, a biotechnology company, focuses on the development of diagnostic tools for the early detection and monitoring of hematological malignancies, particularly breast cancer. The company develops AroCell TK 210 ELISA, an immunoassay kit for the determination of Thymidine Kinase 1 in human blood. It also offers TUBEX TF, a bacteriological rapid test for diagnosis of typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB in 2006. AroCell AB was incorporated in 2000 and is headquartered in Uppsala, Sweden